GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Par Drugs and Chemicals Ltd (NSE:PAR) » Definitions » Float Percentage Of Total Shares Outstanding

Par Drugs and Chemicals (NSE:PAR) Float Percentage Of Total Shares Outstanding : 0.00% (As of May. 13, 2025)


View and export this data going back to 2019. Start your Free Trial

What is Par Drugs and Chemicals Float Percentage Of Total Shares Outstanding?

Float percentage of total shares outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Par Drugs and Chemicals's float shares is 0.00 Mil. Par Drugs and Chemicals's total shares outstanding is 12.30 Mil. Par Drugs and Chemicals's float percentage of total shares outstanding is 0.00%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Par Drugs and Chemicals's Insider Ownership is 0.00%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Par Drugs and Chemicals's Institutional Ownership is 0.00%.


Par Drugs and Chemicals Float Percentage Of Total Shares Outstanding Calculation

It is the percentage of float shares out of the total shares outstanding.

Par Drugs and Chemicals's Float Percentage of Total Shares Outstanding for today is calculated as follows:

Float Percentage of Total Shares Outstanding=Float Shares/Total Shares Outstanding
=0.00/12.30
=0.00%

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Par Drugs and Chemicals Business Description

Industry
Traded in Other Exchanges
N/A
Address
Gotri Vasna Road, 816, Nilamber Triumph, Vadodara, GJ, IND, 390007
Par Drugs and Chemicals Ltd is engaged in the development and manufacture of Active Pharma Ingredients (APIs) for the domestic market as well as for exports to international markets. APIs are the principal ingredient used in making finished dosages in the form of capsules, tablets, liquid, or other forms of dosage. The company is dealing in only one segment i.e. manufacturing industry, API.